Thursday, November 6, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analysts Downgrade Victorias Secret Amidst Negative Developments

Elaine Mendonca by Elaine Mendonca
March 8, 2024
in Breaking News
0
DrugRetailers Stock Bull Market
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

On March 8, 2024, analyst Alice Xiao from B of A Securities made the decision to downgrade Victoria’s Secret (NYSE:VSCO) from Buy to Underperform. She also decreased the price target from $34 to $15. This downgrade comes amidst a series of negative developments for Victoria’s Secret, including a drop in share value following Wells Fargo & Company’s decision to lower the price target on the stock. JPMorgan has also joined in on the pessimism, downgrading Victoria’s Secret to Underweight and setting a price target of $15.00. It appears that the consensus among analysts is that Victoria’s Secret is encountering significant challenges, as multiple firms are revising their ratings and price targets downward.

VSCO Stock Plummets 29.70% Amid Concerns About Companys Future Prospects

On March 8, 2024, VSCO stock experienced a significant drop in its price momentum, trading near the bottom of its 52-week range and below its 200-day simple moving average. The stock closed at $18.01, marking a decrease of $7.61 since the market last closed, representing a 29.70% drop.

Investors and analysts are closely monitoring the performance of VSCO stock as it continues to face challenges in the market. The drop in price momentum has raised concerns among shareholders about the company’s financial health and future prospects.

In pre-market trading on March 8, 2024, VSCO stock continued to decline, dropping an additional $0.06. This downward trend has sparked speculation about the factors contributing to the stock’s poor performance and whether the company will be able to rebound in the near future.

VSCO Stock Performance Analysis: Revenue Holds Flat, EPS Sees Impressive Increase

VSCO, the popular photo editing and sharing app, has been making headlines recently with its stock performances on March 8, 2024. According to data from CNN Money, the company reported total revenue of $6.18 billion for the past year, which remained flat compared to the previous year. Similarly, the total revenue for the last quarter was $2.08 billion, also holding flat since the previous quarter.

While the total revenue figures may not show significant growth, VSCO did see some fluctuations in its net income and earnings per share (EPS) numbers. The net income for the past year was reported at $109.20 million, a decrease of 68.62% compared to the previous year. However, the net income for the last quarter was $181.09 million, holding flat compared to the previous quarter.

In terms of EPS, VSCO reported $1.39 for the past year, showing a decrease of 66.45% compared to the previous year. However, the EPS for the last quarter was $2.29, indicating an impressive increase of 348.88% compared to the previous quarter.

These numbers suggest that VSCO has been able to maintain its revenue levels while seeing fluctuations in its net income and EPS figures. The increase in EPS for the last quarter could be a positive sign for investors, indicating potential growth in the future.

Investors should conduct thorough research and analysis before making any investment decisions. Overall, VSCO’s stock performances on March 8, 2024, show a mixed picture with some positive indicators in terms of EPS growth, despite fluctuations in net income. It will be interesting to see how the company continues to perform in the coming months and whether it can sustain its growth trajectory.

Tags: VSCO
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_Cash

UBS Analyst Downgrades Maxeon Solar Technologies Ltd from Neutral to Sell

Food Retailers Stock Bull Market

Analyst Perspectives on BJs Wholesale Club A Mixed Bag of Opinions

Finance_Assets (3)

CNBC Experts Share Final Trades for March 8 2024

Recommended

Baidu Stock

Baidu’s Strategic Moves in Autonomous Driving and AI Draw Mixed Investor Reactions

1 month ago

Windtree Therapeutics Achieves Financial Stability and Advances Clinical Programs

2 years ago
Technology Data analytics Stock Bull Market

Anticipation High for Adobes FirstQuarter Financial Results and AI Innovation

2 years ago
Ideaya Biosciences Stock

Ideaya Biosciences: A Tale of Market Skepticism and Clinical Promise

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

EU Grant Provides Critical Boost for LanzaTech’s Carbon Recycling Technology

Is Darden Restaurants Facing a Critical Test?

Critical Juncture for USA Rare Earth as Earnings and Chinese Export Curbs Collide

AES Shares Surge on Potential $38 Billion Acquisition Speculation

Kura Oncology Investors Await Crucial FDA Verdict

Cadence Design Stock: A Battle Between Fundamentals and Market Signals

Trending

DuPont de Nemours Stock
Analysis

DuPont Faces Critical Test as Quarterly Results Loom

by Dieter Jaworski
November 6, 2025
0

DuPont de Nemours finds itself at a pivotal moment as the chemical giant prepares to release quarterly...

Sarepta Therapeutics Stock

Sarepta Therapeutics Shares Plummet Following Critical Clinical Trial Failure

November 6, 2025
Emerson Electric Stock

Emerson Electric’s Strategic Pivot Faces Market Scrutiny

November 6, 2025
Lanzatech Global Stock

EU Grant Provides Critical Boost for LanzaTech’s Carbon Recycling Technology

November 6, 2025
Darden Restaurants Stock

Is Darden Restaurants Facing a Critical Test?

November 6, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • DuPont Faces Critical Test as Quarterly Results Loom
  • Sarepta Therapeutics Shares Plummet Following Critical Clinical Trial Failure
  • Emerson Electric’s Strategic Pivot Faces Market Scrutiny

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com